Alliancebernstein L.P. lessened its stake in Xylem Inc. (NYSE:XYL - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 283,146 shares of the industrial products company's stock after selling 25,854 shares during the quarter. Alliancebernstein L.P. owned 0.12% of Xylem worth $32,851,000 as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Lee Danner & Bass Inc. purchased a new position in Xylem in the fourth quarter valued at $30,000. Rialto Wealth Management LLC acquired a new stake in shares of Xylem during the 4th quarter valued at about $31,000. Heck Capital Advisors LLC purchased a new position in shares of Xylem in the 4th quarter valued at about $36,000. Pathway Financial Advisers LLC raised its holdings in Xylem by 122.4% in the 4th quarter. Pathway Financial Advisers LLC now owns 318 shares of the industrial products company's stock worth $37,000 after purchasing an additional 175 shares during the period. Finally, SRS Capital Advisors Inc. boosted its position in Xylem by 69.5% during the fourth quarter. SRS Capital Advisors Inc. now owns 317 shares of the industrial products company's stock worth $37,000 after purchasing an additional 130 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Price Performance
Shares of NYSE:XYL traded up $1.26 during midday trading on Friday, hitting $108.94. The company's stock had a trading volume of 1,938,139 shares, compared to its average volume of 1,374,462. Xylem Inc. has a 12-month low of $100.47 and a 12-month high of $146.08. The company has a market cap of $26.51 billion, a P/E ratio of 29.76, a price-to-earnings-growth ratio of 2.33 and a beta of 1.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.76. The business's 50 day simple moving average is $122.72 and its 200 day simple moving average is $124.02.
Xylem (NYSE:XYL - Get Free Report) last issued its earnings results on Tuesday, February 4th. The industrial products company reported $1.18 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.06. The business had revenue of $2.30 billion for the quarter, compared to analysts' expectations of $2.18 billion. Xylem had a return on equity of 9.96% and a net margin of 10.40%. The business's revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.99 EPS. On average, analysts forecast that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 19th. Shareholders of record on Tuesday, February 18th were issued a $0.40 dividend. This is a boost from Xylem's previous quarterly dividend of $0.36. This represents a $1.60 annualized dividend and a yield of 1.47%. The ex-dividend date was Tuesday, February 18th. Xylem's dividend payout ratio is presently 43.72%.
Wall Street Analysts Forecast Growth
XYL has been the subject of a number of recent analyst reports. Wolfe Research restated a "peer perform" rating on shares of Xylem in a research report on Thursday, December 12th. Citigroup lowered shares of Xylem from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 5th. Robert W. Baird increased their price objective on shares of Xylem from $139.00 to $148.00 and gave the company an "outperform" rating in a report on Wednesday, February 5th. Finally, Stifel Nicolaus cut their target price on shares of Xylem from $166.00 to $150.00 and set a "buy" rating for the company in a research note on Friday, January 24th. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $149.89.
Check Out Our Latest Research Report on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories

Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.